In MM, SPRED1 loss rarely co-occurs with BRAF mutations, NRAS mutations, or NF1 inactivation mutations (6), indicating those alterations play similar roles in activating MAPK pathway signaling in MM. This evidence concerns the gene SPRED1 and Miyoshi myopathy.